FDA Adverse Event Injury Summary report: N

TOTAL ASR FEM IMP SIZE 49

MDR report key: 3053443 · Received April 11, 2013

Report

Report Number
1818910-2013-04730
Event Type
Injury
Date Received
April 11, 2013
Date of Event
February 6, 2013
Report Date
July 1, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KXA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

ADDITIONAL NARRATIVE: IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Description of Event or Problem · 1

ASR REVISION; ASR XL- LEFT HIP; REASON FOR REVISION: PAIN.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4). REASON FOR ORIGINAL COMPLAINT - ASR REVISION; ASR XL- LEFT; REASON(S) FOR REVISION: PAIN. UPDATE RECEIVED: 1ST JULY 2014 - ADDED FURTHER REASON(S) FOR REVISION: ALVAL / SOFT TISSUE REACTION AND IMPINGEMENT ON ANTERIOR ACETABULAR OSTEOPHYTE, ADDED SURGEON: (B)(6) AND AMENDED REVISION DATE: (B)(6) 2013.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
154435 TOTAL ASR FEM IMP SIZE 49 HIP FEMORAL HEAD KXA DEPUY INTERNATIONAL LTD. 8010379 2732785

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention